annual EBITDA:
-$339.66M-$109.72M(-47.72%)Summary
- As of today (September 16, 2025), SNDX annual EBITDA is -$339.66 million, with the most recent change of -$109.72 million (-47.72%) on December 31, 2024.
- During the last 3 years, SNDX annual EBITDA has fallen by -$366.34 million (-1373.29%).
- SNDX annual EBITDA is now -1373.29% below its all-time high of $26.68 million, reached on December 31, 2021.
Performance
SNDX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$63.99M+$12.81M(+16.68%)Summary
- As of today (September 16, 2025), SNDX quarterly EBITDA is -$63.99 million, with the most recent change of +$12.81 million (+16.68%) on June 30, 2025.
- Over the past year, SNDX quarterly EBITDA has increased by +$4.03 million (+5.92%).
- SNDX quarterly EBITDA is now -166.52% below its all-time high of $96.20 million, reached on December 31, 2021.
Performance
SNDX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$314.25M+$4.03M(+1.26%)Summary
- As of today (September 16, 2025), SNDX TTM EBITDA is -$314.25 million, with the most recent change of +$4.03 million (+1.26%) on June 30, 2025.
- Over the past year, SNDX TTM EBITDA has dropped by -$50.41 million (-19.11%).
- SNDX TTM EBITDA is now -1269.60% below its all-time high of $26.87 million, reached on December 31, 2021.
Performance
SNDX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SNDX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.7% | +5.9% | -19.1% |
| 3 y3 years | -1373.3% | -73.6% | -10000.0% |
| 5 y5 years | -495.0% | -290.1% | -448.2% |
SNDX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1373.3% | at low | -90.2% | +28.4% | <-9999.0% | +1.3% |
| 5 y | 5-year | -1373.3% | at low | -166.5% | +28.4% | -1269.6% | +1.3% |
| alltime | all time | -1373.3% | at low | -166.5% | +28.4% | -1269.6% | +1.3% |
SNDX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$63.99M(-16.7%) | -$314.25M(-1.3%) |
| Mar 2025 | - | -$76.80M(-14.1%) | -$318.27M(+1.4%) |
| Dec 2024 | -$339.66M(+47.7%) | -$89.36M(+6.3%) | -$313.82M(+5.7%) |
| Sep 2024 | - | -$84.10M(+23.7%) | -$296.87M(+12.5%) |
| Jun 2024 | - | -$68.02M(-6.0%) | -$263.84M(+9.7%) |
| Mar 2024 | - | -$72.34M(-0.1%) | -$240.40M(+14.9%) |
| Dec 2023 | -$229.94M(+52.0%) | -$72.41M(+41.8%) | -$209.14M(+18.9%) |
| Sep 2023 | - | -$51.07M(+14.6%) | -$175.88M(+11.0%) |
| Jun 2023 | - | -$44.58M(+8.5%) | -$158.46M(+5.1%) |
| Mar 2023 | - | -$41.08M(+4.9%) | -$150.74M(+3.1%) |
| Dec 2022 | -$151.30M(-667.2%) | -$39.15M(+16.3%) | -$146.17M(+1251.0%) |
| Sep 2022 | - | -$33.65M(-8.7%) | -$10.82M(-480.1%) |
| Jun 2022 | - | -$36.87M(+1.0%) | $2.85M(-83.7%) |
| Mar 2022 | - | -$36.51M(-137.9%) | $17.45M(-35.1%) |
| Dec 2021 | $26.68M(-137.6%) | $96.20M(-581.4%) | $26.87M(-130.2%) |
| Sep 2021 | - | -$19.98M(-10.3%) | -$89.10M(+0.2%) |
| Jun 2021 | - | -$22.27M(-17.8%) | -$88.90M(+7.1%) |
| Mar 2021 | - | -$27.08M(+37.0%) | -$83.03M(+17.4%) |
| Dec 2020 | -$70.91M(+24.2%) | -$19.77M(-0.1%) | -$70.71M(+10.0%) |
| Sep 2020 | - | -$19.78M(+20.6%) | -$64.27M(+12.1%) |
| Jun 2020 | - | -$16.40M(+11.1%) | -$57.32M(+2.7%) |
| Mar 2020 | - | -$14.76M(+10.8%) | -$55.84M(+0.8%) |
| Dec 2019 | -$57.09M | -$13.33M(+3.9%) | -$55.38M(-6.3%) |
| Sep 2019 | - | -$12.83M(-14.0%) | -$59.10M(-7.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$14.92M(+4.3%) | -$64.12M(-5.9%) |
| Mar 2019 | - | -$14.30M(-16.2%) | -$68.15M(-7.4%) |
| Dec 2018 | -$75.80M(+22.5%) | -$17.06M(-4.4%) | -$73.60M(-3.2%) |
| Sep 2018 | - | -$17.84M(-5.9%) | -$76.03M(+3.5%) |
| Jun 2018 | - | -$18.95M(-4.1%) | -$73.48M(+7.6%) |
| Mar 2018 | - | -$19.75M(+1.3%) | -$68.30M(+10.7%) |
| Dec 2017 | -$61.88M(+41.7%) | -$19.49M(+27.4%) | -$61.72M(+15.9%) |
| Sep 2017 | - | -$15.29M(+11.1%) | -$53.27M(+0.1%) |
| Jun 2017 | - | -$13.77M(+4.5%) | -$53.22M(+10.7%) |
| Mar 2017 | - | -$13.17M(+19.3%) | -$48.08M(+10.3%) |
| Dec 2016 | -$43.68M(+113.1%) | -$11.04M(-27.5%) | -$43.61M(+33.9%) |
| Sep 2016 | - | -$15.24M(+76.6%) | -$32.57M(+87.9%) |
| Jun 2016 | - | -$8.63M(-0.8%) | -$17.33M(+99.2%) |
| Mar 2016 | - | -$8.70M(+12.5%) | -$8.70M(-58.4%) |
| Dec 2015 | -$20.49M(-3.9%) | - | - |
| Dec 2014 | -$21.32M(+149.1%) | - | - |
| Sep 2014 | - | -$7.73M(+22.3%) | -$20.91M(+35.3%) |
| Jun 2014 | - | -$6.32M(+58.9%) | -$15.46M(+69.2%) |
| Mar 2014 | - | -$3.98M(+38.4%) | -$9.14M(+41.4%) |
| Dec 2013 | -$8.56M(-1.6%) | -$2.88M(+25.9%) | -$6.46M(+80.1%) |
| Sep 2013 | - | -$2.28M(+74.9%) | -$3.59M(+174.9%) |
| Mar 2013 | - | -$1.30M | -$1.30M |
| Dec 2012 | -$8.70M(-9.1%) | - | - |
| Dec 2011 | -$9.57M | - | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Syndax Pharmaceuticals, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of SNDX is -$339.66M
What is the all time high annual EBITDA for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual EBITDA is $26.68M
What is Syndax Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, SNDX annual EBITDA has changed by -$109.72M (-47.72%)
What is Syndax Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of SNDX is -$63.99M
What is the all time high quarterly EBITDA for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly EBITDA is $96.20M
What is Syndax Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, SNDX quarterly EBITDA has changed by +$4.03M (+5.92%)
What is Syndax Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of SNDX is -$314.25M
What is the all time high TTM EBITDA for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high TTM EBITDA is $26.87M
What is Syndax Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, SNDX TTM EBITDA has changed by -$50.41M (-19.11%)